Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland

Drugs and Aging

Volumn 30, Issue 7, 2013, Pages 561-568

  Blozik, Eva ^a,b   Rapold, Roland ^c   Von Overbeck, Jan ^a   Reich, Oliver ^c  

^a Swiss Center for Telemedicine Medgate   (Switzerland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Helsana Group   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACEMETACIN; AMIODARONE; ANTIANEMIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; ANTIRHEUMATIC AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; DOXAZOSIN; ESTRADIOL; FERROUS SULFATE; LAXATIVE; LIQUID PARAFFIN; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; OXYBUTYNIN; PENTOXIFYLLINE; PRASUGREL; SEX HORMONE; SOTALOL; TETRAHYDROLIPSTATIN; TRIMIPRAMINE; UNINDEXED DRUG; VASODILATOR AGENT; ZOLPIDEM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNITY LIVING; DRUG COST; FEMALE; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PREVALENCE; PRIORITY JOURNAL; REIMBURSEMENT; SEX RATIO; SWITZERLAND;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PREVALENCE; RESIDENCE CHARACTERISTICS; SWITZERLAND;

EID: 84879520263     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0073-0     Document Type: Article

References (33)

1. World Health Organization, Medicines: safety of medicines - adverse drug reactions, Fact sheet No 293 [online]. 2008. http://www.who.int/mediacentre/ factsheets/fs293/en/index.html. Accessed 04 Oct 2012.
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9.
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9.
4. Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging. 2010;27(5):407-15.
5. Ruggiero C, Dell'Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747-58.
6. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22(1):69-82.
7. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123-32.
8. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447-50.
9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997;157(14):1531-6.
10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24.
11. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-31.
12. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385-91.
13. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725-31.
14. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31-32):543-51.
15. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543-52.
16. Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Therap. 2007;45(12):643-53.
17. Egger SS, Bachmann A, Hubmann N, Schlienger RG, Krähenbühl S. Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging. 2006;23(10):823-37.
18. Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348-58.
19. Hanlon JT, Schmader K, Ruby C, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49(2):200-9.
20. Federal Office of Public Health. Bundesgesetz vom 18. März 1994 über die Krankenversicherung (KVG) [online]. http://www.admin.ch/ch/d/sr/ c832-10.html. Accessed 04 Oct 2012.
21. Hertzlinger RE, Parsa-Parsi R. Consumer-driven health care: lessons from Switzerland. JAMA. 2004;292(10):1213-20.
22. World Health Organization. ATC/ DDD Index 2012 [online]. http://www.whocc.no/atc-ddd-index/. Accessed 04 Oct 2012.
23. Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging. 2007;24(1):37-55.
24. Interpharma. Pharma-Markt Schweiz 2012 [online]. http://www.interpharma. ch/de/fakten-und-statistiken/Pharma-Markt-Schweiz.asp. Accessed 04 Oct 2012.
25. Rochon P, Gurwitz J. Prescribing for seniors: neither too much nor too little. JAMA. 1999;282(2):113-5.
26. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10:16.
27. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019-28.
28. Amann U, Schmedt N, Garbe E. Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS List. Dtsch Arztebl Int. 2012;109(5):69-75.
29. Felder S, Meier M, Schmitt H. Health care expenditure in the last months of life. J Health Econ. 2000;19(5):679-95.
30. Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of 'red herrings'? Health Econ. 2007;16(10):1109-26.
31. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845-54.
32. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891-6.
33. Organisation for Economic Co-operation and Development. OECD Reviews of Health Systems - Switzerland [online]. http://www.oecd.org/health/ healthpoliciesanddata/oecdreviewsofhealthsystems-switzerland.htm. Accessed 04 Oct 2012.